Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. HC Wainwright & Co. boosted the price target for Avadel Pharmaceuticals plc (NASDAQ:AVDL) from $21 to $25. HC Wainwright & Co. analyst Oren Livnat maintained a Buy rating. Avadel Pharmaceuticals shares gained 17.6% to close at $16.13 on Monday. See how other analysts view this stock.Barclays cut the price target for Noble Corporation plc (NYSE:NE) from $61 to $59. Barclays analyst Eddie Kim maintained an Overweight rating. Noble shares fell 0.8% to close at
海量资讯、精准解读，尽在新浪财经APP
VIP课程推荐
加载中...
APP专享直播
热门推荐
收起
新浪财经公众号
24小时滚动播报最新的财经资讯和视频，更多粉丝福利扫描二维码关注（sinafinance）
